Axons of midbrain dopaminergic neurons innervate the striatum where they 28 contribute to movement and reinforcement learning. Past work has shown that striatal 29 GABA tonically inhibits dopamine release, but whether GABA-A receptors directly 30 modulate transmission or act indirectly through circuit elements is unresolved. Here, we 31 use whole-cell and perforated-patch recordings to test for GABA-A receptors on the 32 main dopaminergic neuron axons and branching processes within striatum. Application 33 of GABA depolarized axons, but also decreased the amplitude of axonal spikes, limited 34 propagation and reduced striatal dopamine release. The mechanism of inhibition 35 involved sodium channel inactivation and shunting. Lastly, we show that the positive 36 allosteric modulator diazepam enhanced GABA-A currents on dopaminergic neuron 37 axons and directly inhibited release, but also likely acts by reducing excitatory drive 38 from cholinergic interneurons. Thus, we reveal the mechanisms of GABA-A receptor 39 modulation of dopamine release and provide new insight into the actions of 40 benzodiazepines within the striatum.
was then applied onto the axon with a short pressure ejection (80 -300 ms in duration) 165 using a PV 820 Pneumatic PicoPump (WPI). 166 Fast-scan cyclic voltammetry (FSCV) 167 For all voltammetry experiments the methods are as follow. Cylindrical carbon-fiber 168 electrodes (CFEs) were prepared with T650 fibers (6 μm diameter, ~150 μm of exposed 169 fiber) inserted into a glass pipette and filled with KCl (3 M). Before use, the CFEs were For voltammetry experiments performed by J.H.S., the methods are as follows. 181 Mice were anesthetized with isoflurane and sacrificed by decapitation. Brains were 182 sliced in sagittal orientation at 240 µm thickness with a vibratome (VT-1200S Leica) in 183 an ice-cold cutting solution containing (in mM) 225 sucrose, 13.9 NaCl, 26.2 NaHCO3, 1 184 NaH2PO4, 1.25 glucose, 2.5 KCl, 0.1 CaCl2, 4.9 MgCl2, and 3 kynurenic acid. Slices 185 were incubated for 20 min at 33 °C in artificial cerebrospinal fluid (ACSF) containing (in 186 mM) 124 NaCl, 1 NaH2PO4, 2.5 KCl, 1.3 MgCl2, 2.5 CaCl2, 20 glucose, 26.2 NaHCO3, 187 0.4 ascorbic acid, and maintained at room temperature prior recordings. Slices were 188 placed in a submerged chamber perfused at 2 ml/min with ACSF at 32 °C using an in-189 line heater (Harvard Apparatus). . For the immunostaining/CUBIC clearing, all steps were performed at room 213 temperature on shaker plate. Slices were placed in CUBIC reagent 1 for 1-2 days, 214 washed in PB 3 x 1 hour each, placed in blocking solution (0.5% fish gelatin (Sigma) in 215 PB) for 3 hours. Slices were directly placed in streptavidin-Cy5 conjugate at a 216 concentration of 1:1000 in PB for 2-3 days. Slices were washed 3 times for 2 hours 217 each and were then placed in CUBIC reagent 2 overnight. Slices were mounted on 218 slides in reagent 2 in frame-seal incubation chambers (Bio-Rad SLF0601) and 219 coverslipped (#2 glass). Slices were imaged through 20×, 0.8 nA and 5×, 0.3 nA 220 objectives on an LSM 800 confocal microscope (Zeiss), and taken as tiled z-stacks 221 using Zen Blue software in the NINDS light imaging facility.
222
Main axons were reconstructed and measured using Simple Neurite Tracer in 223 FIJI (Longair et al., 2011) . Of axons with a positively identified soma, the majority were found in the substantia nigra pars compacta, with some found in the ventral tegmental 225 area. Striatal axons were reconstructed using Neurolucida (MBF bioscience).
226

Drugs 227
All salts and all drugs not otherwise stated were from Sigma-Aldrich. Fluo5F and 228 Alexa594 (Life Technologies), gabazine, d-AP5, hexamethonium chloride, oxotremorine 229 M, GABA, and muscimol, were dissolved in deionized water. Sulpiride, quinpirole, 230 picrotoxin, CGP55845 (Tocris), NBQX, and diazepam were dissolved in DMSO.
231
Atropine was dissolved in DMSO and then diluted 1:10 in deionized water.
232
Quantification and Statistical Analysis
233
Analysis was conducted in Igor Pro and Prism 8 (GraphPad). Data in text is 234 reported as mean ( ̅ ) ± SEM for parametric or median ( �) for non-parametric data. Error 235 bars on graphs are indicated as ± SEM. Box plots show medians, 25 and 75% (boxes) 236 percentiles, and 10 and 90% (whiskers) percentiles. For parametric data, t-tests were 237 used for two-group comparison, and ANOVA tests were used for more than two group Prism, and an extra sum-of-squares F test was performed to determine significant 243 differences in slope between data sets on the same plot, and to determine whether a 244 line or exponential decay model fits the data better. For exponential fits, the One Phase 245 Decay analysis function in Prism was used to fit a standard curve. Figure 1F ; avg. dV/dt, soma: �=49.9 mV/s n=10; U=22, p<0.0001), similar to 275 previously reported values (Khaliq and Bean, 2008) . A plot of the slope of the interspike 276 voltage against the axonal recording distance followed a roughly exponential 277 relationship with the interspike slope, such that it becomes more shallow with increasing 278 recording distance ( Figure 1G ; single exponential fit, length constant, λ=211 µm, n=27; 279 R 2 =0.70; data were fit with a single exponential significantly better than with a line: Main axon recorded in whole-cell mode with a connected soma (filled with neurobiotin, imaged with streptavidin-Cy5, slice cleared with CUBIC, red); GFP driven by the TH promoter (green). B. Trace of spontaneous action potentials recorded from a dopaminergic axon (left). Firing rate from somatic (n=10) and axonal recordings (n=41; p=0.298) (right). C. Overlay of an axonal and somatic spike (left). Phase plot for a somatic and axonal action potential (right). D. Half-peak width from somatic (n=10) and axonal (n=27) APs (**p=0.008) E. AP threshold between soma (n=10) and axon (n=26)(****p<0.0001) F. Example traces of interspike voltage from obtained from axonal (blue) and somatic (gray) recordings. G. Slope of interspike voltage plotted against recording distance between axonal recording site (blue) and soma (gray). H. Post-hoc reconstruction of a patched striatal axon I. Trace of subthreshold depolarization (left) and axonal AP (right) evoked by 250 pA and 275 pA current injection. J. Input resistance values for main axon (n=28) and striatal axons (n=74) APs (****p<0.0001) K. Comparison of the mean interspike voltage between soma (n=10) main axon (n=21) and striatal axon, which was measured as the average resting membrane potential (n=74) (*p=0.032; ***p=0.0007; ns p=0.87). 
Identification of GABA-A receptor-mediated currents on dopaminergic neuron axons 301
Past work has shown that GABA-A receptors modulate dopamine release but 302 evidence that GABA-A receptors are located on dopaminergic neuron axons has been 303 indirect. To test for a GABA-A receptor-mediated conductance in the axon, a second 304 pipette was placed 30-60 µm from the axonal recording site on the main axon and 305 GABA (300 µM-1 mM) was locally applied by a brief (80-300 ms) pressure ejection 306 (Figure 2A of these currents, we tested the effect of increasing the concentration of intracellular 310 chloride on the GABA-mediated depolarization. We found that filling axons with an To better understand how axonal GABA-A receptors inhibit dopamine release, 369 we tested the effect of GABA-A receptor activation on axonal action potential 370 waveforms. As shown in Figure 4A , the most prominent effect of GABA-A receptor 371 activation was a shortening of the action potential peak. Although the effect of GABA on 372 spike height varied between axons, we found that the peak was shortened on average 373 by 7.74 ± 1.83 mV (avg. peak amplitude; control, ̅ =12.5 ± 4.72 mV; GABA, ̅ =4.77 ± 374 5.22 mV; 2-way ANOVA Bonferroni's post-hoc t(12)=5.75; n=7, p=0.0002). This effect was blocked completely by picrotoxin (peak reduction in picrotoxin; control peak, ̅ =-376 1.86 ± 5.34 mV, GABA peak ̅ =-3.88 ± 5.02 mV; 2-way ANOVA Bonferroni's post-hoc 377 t(12)=1.49; n=7, p=0.32). We took advantage of the variability between axons in their 378 responses to GABA in order to assess the relationship between the GABA-A mediated 379 depolarization and spike height. Plotting data from 14 axon recordings, we found that 380 the reduction in spike height correlates linearly with the GABA-mediated depolarization 381 with a slope of -1.50 mV/mV (95% CI: -2.05 to -0.94; R 2 =0.74, n=14; Figure 4C 
387
To dissect the contribution from these two processes, we compared the GABA puff 388 experiments in Figure 4A to separate experiments where depolarization was evoked 389 instead by direct current injection ( Figure 4B ). We reasoned that the effects of current 390 injection-evoked depolarization on spike height should be dominated by sodium channel 391 inactivation whereas shunting inhibition should be minimal under these conditions.
392
Plotting the spike height against current injection-evoked depolarization in Figure 4C 393 (brown symbols), we found that direct current injections were significantly less effective 394 at reducing spike peak amplitudes as compared to GABA mediated depolarization as 395 revealed by shallower slope of best-fit lines ( Figure 4C ; GABA-A activation: -1.50 396 mV/mV, 95% CI: -2.05 to -0.94; direct depolarization: -0.77 mV/mV, 95% CI: -0.96 to -397 0.59; F(1,25)=4.39, n=29, p=0.047). We next analyzed the rate of the rise of the action 398 potential (dV/dt) as it reflects the maximal spike-evoked sodium current. By contrast, we 399 found little difference in the effect of GABA-evoked and direct current injection-evoked 400 depolarization on the rate of rise of axonal action potentials (dV/dt). Plots in Figure 4D upstroke denotes area of measurement for rate of rise, arrows denoting measurement of 7 change in AP peak and change in membrane potential C. Effect of the amount of baseline 8 depolarization on the decrease in peak AP amplitude, compared between GABA (green; n=14) 9
and current injection (tan; n=15) (*p=0.047) D. Effect of the amount of baseline depolarization 10 on the normalized decrease in rate of AP upstroke, compared between GABA (green; n=11) 11
and current injection (tan; n=10) (ns p=0.564 showing the effect of TTX on action potential peak amplitude (graphs were aligned to the 18 beginning of TTX effect, n=5). The decrease in peak amplitude is plotted in G. G. Data from five 19
individual axons showing the effect of TTX wash-in on the change in rate of action potential rise, 20 and the change in the peak of the action potential. Each dot in data from an individual action 21 potential, normalized to just before the perfusion of TTX. In red is the average effect. H. Slope 22
and R 2 values from E and G compared. 23
These data suggested the peak amplitude of the action potential was susceptible 406 to both depolarizations and shunting inhibition, while the rate of rise was only affected 407 by depolarizations. In order to combine these two effects and distinguish between 408 shunting inhibition and depolarization-mediated inactivation of sodium channels, the 409 change in rate of rise was graphed against the change in peak spike amplitude. From 
414
To experimentally test the effect of sodium channel inhibition on axonal action 415 potentials, TTX was bath perfused while recording axonal action potentials ( Figure 4F ).
416
As the effect of TTX developed, the amplitude of the peak of the action potential was 417 progressively reduced, and the rate of rise was progressively slowed ( Figure 4F-H) . We 418 compared the relationship of the reduction in the peak and the slowing of the rate of rise 419 across groups and found that the average of the TTX condition was similar to the direct 420 depolarization, indicating this effect was mainly through inactivation of sodium channels. ). We therefore sought to determine the contribution of GABA-A receptors on 437 dopamine neuron axons to the effects of diazepam. 438 We first tested the effect to inhibiting both GABA-A and GABA-B receptors in the 439 striatum in the absence of any exogenously applied agonist. We found that co-440 application of GABA-A (GABAzine) and GABA-B (CGP-55845) antagonists significantly 441 enhanced dopamine release to 115% of baseline ( Figure 5A Figure 5D ; diazepam: 50.7 ± 11.3% of baseline; RM 1-way ANOVA Bonferroni's post-458 hoc t(4)=4.37; p=0.024, n=5 slices). The diazepam-mediated inhibition was significantly 459 greater compared to when cholinergic input was blocked (two-tailed t-test; t(9)=2.47, 460 p=0.035).
461
To understand the mechanism behind this inhibition in the dopamine neuron 462 axons we performed direct recordings from the axon. First, we sought to investigate 463 whether these axonal GABA-A receptors are directly modulated by diazepam. For this 464 experiment we puffed on muscimol in a voltage-clamp recording of the main axon, and 465 then bath perfused diazepam (10 µM). Diazepam dramatically increased the amplitude 466 of the muscimol-evoked current (Figure 5E,G) . We also tested the effect of diazepam on Example dopamine transient in control (black) and in GZ/CGP (red). Right: Plot of the average 5 increase in peak optically-evoked dopamine release (each dot is one slice; n=10, p = 0.015). C. 6
Example traces of imaged dopamine release from control (black) and diazepam bath perfusion 7
(green) conditions. Right: Group effect of diazepam on peak dopamine release (n=6; *p=0.044). diazepam bath application on the normalized muscimol-evoked peak current (n=6). H. Left: 16 example current injections to test axonal input resistance in control (black) diazepam (green) 17
and GABA-A antagonists picrotoxin and GABAzine (red) conditions. Right: time course of 18 diazepam bath perfusion followed by GABA-A antagonist bath perfusion on the normalized 19 axonal input resistance. 20 the input resistance by giving a small voltage step ( Figure 5E ). We found that, in the 468 main axon, there was no effect of diazepam perfusion on the axonal input resistance 469 ( Figure 5F ). This set of experiments show that diazepam directly targets axonal GABA-470 A receptors on dopamine neurons, but in the medial fiber bundle GABA-A agonists must 471 be exogenously applied to observe the effects of the drug.
472
Given the effect of diazepam on dopamine release reported above, we 473 hypothesized that diazepam might be acting in concert with the striatal GABA tone to 474 modulate dopamine neuron axons. When we recorded from striatal dopamine neuron 475 axons and bath perfused diazepam, we found that diazepam decreased the input 476 resistance of the axon in the striatum by an average of 22.7 ± 6.2% ( Figure 5H 2012; Kole et al., 2007) . We also find that action potentials are initiated from spike 511 thresholds that are 14.3 mV more hyperpolarized than somatic spikes. Furthermore, the 512 average non-spike voltage recorded in both the main axon and striatal axon is 6.7 mV 513 and 8.8 mV more negative than values reported for the soma, which also fits with data 514 from cortical layer 5 pyramidal neurons (Hu and Bean, 2018) . The hyperpolarized membrane potential of the axon suggests that further 527 hyperpolarization by Kv1 may be limited by the potassium reversal potential and may 528 not be the main mechanism of dopamine inhibition. Consistent with the proposal by 529 Martel and colleagues (2011), shunting and/or changes in spike shape are likely to 530 underlie the D2-dependent inhibition of dopamine release.
531
In somatic recordings of pacemaking, dopaminergic neurons exhibit a gradual 532 depolarization of the interspike voltage thought to be critical for the generation of 533 spontaneous activity (Kang and Kitai, 1993; Khaliq and Bean, 2008) . By contrast, our 534 data from distal recordings show that the slope of the interspike axonal membrane 535 potential was shallow. The shallower interspike depolarization in the axon suggests that 536 pacemaking in dopaminergic neurons results largely from excitability of the soma and 537 dendrites. Furthermore, hyperpolarized axonal threshold potential suggests that our 538 recording site in the axon is distal to the site of action potential initiation, which is the 539 axon initial segment (Hausser et al., 1995; Shu et al., 2007) . Therefore, these 540 observations argue against the axon as a third site of oscillation generation after the 541 soma and dendrites (Pissadaki and Bolam, 2013) . It is important to note that although conductances that are depolarizing relative to resting membrane potential.
565
In this study, we demonstrate that the average reversal potential of GABA-mediated 566 currents in dopamine neuron axons, when considered relative to the average axonal 567 interspike membrane potential of -68 mV, is also depolarized at -56 mV. Our recordings 568 were performed in adult mice (ages 6-17 weeks, median of 15.5 weeks) suggesting that 569 the depolarized reversal potential that we obtained represents the value in mature 570 axons. Interestingly, the reversal potential for somatodendritic GABA currents in 571 dopaminergic neurons is also depolarized at -63 mV due to relatively low expression of 572 the K-Cl cotransporter KCC2 (Gulacsi et al., 2003) , which is similar to the average 573 interspike membrane potential of dopamine neurons during pacemaking. Therefore, 574 activation of somatodendritic GABA-A receptors reduces spiking primarily through 575 shunting with relatively little change in the membrane potential. Past studies have proposed that presynaptic GABA-A receptors exert their effects 606 through either shunting inhibition or sodium channel inactivation (Trigo et al., 2008) .
607
Because of the lack of experimental access to the axonal compartment, however, direct
